Onalespib

N/A

Report date: 2023/05/05 17:41:05
NME

Base Information

Drug NameOnalespib
Drug Alias Name奥那司匹AT-13387AT-13387X
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHeat shock protein HSP90 inhibitors
TargetsHeat shock protein HSP90
Therapy Area/IndicationsMetastatic breast cancerSkin MelanomaSolid tumours +[23
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesUnited Kingdom +[6
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAstex Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesAstex Pharmaceuticals Inc
Active IndicationsSolid tumoursOvarian DiseasesFallopian Tube Diseases +[11
Inactive IndicationsMetastatic breast cancerSkin MelanomaProstatic Neoplasms +[12

Other Information

ATC CodeN/A
Related LinksKEGG